17th International Congress of Virology
Programme

Monday 17 July
Tuesday 18 July
Wednesday 19 July
Thursday 20 July
Friday 21 July

Bridging Session
Frontiers in Structural Microbiology

Dr Eric Westhof, Université de Strasbourg, France
 
Prof Erica Ollmann Saphire, The Scripps Research Institute, USA

Workshop Sessions 1

  • 100 years of Phage
    Prof Ipek Kurtboke, University of the Sunshine Coast, Australia
     
  • Virus Entry, Fusion, Assembly and Budding
    Prof Fasseli Coulibaly, Monash University, Australia
     
  • Paramyxoviruses I
    Prof Danielle Anderson, Duke-NUS Medical School, Singapore
     
  • Positive RNA Viruses I
    Prof Vincent Chow, National University of Singapore, Singapore

Workshop Sessions 2

  • Insect Viruses
    Prof Jody Hobson-Peters, The University of Queensland, Australia
     
  • Influenza Virus
    Prof Ling Chen, Guangzhou Institute of Biomedicine and Health, China
     
  • Paramyxoviruses II
    Prof Benhur Lee, Icahn School Of Medicine At Mount Sinai, USA
     
  • Positive RNA Viruses II
    Prof Justin Chu, National University of Singapore, Singapore

ICV-Plenary
Virus-Host Interactions

Coronavirus Diversity, Phylogeny and Interspecies Jumping
Prof Patrick CY Woo, Hong Kong University, Hong Kong SAR
 
Morbillivirus Pathogenensis - What We Know and What We Don't
Dr Veronika von Messling, Paul-Ehrlich-Institut, Germany

Arima and Mudd Awards Ceremony

Science and Society: Infectious Diseases As An Example
Prof Jörg Hacker, President of the German Academy of Sciences Leopoldina – National Academy of Sciences

ICV-Plenary
New and Emerging Viruses I

Ebola Virus – Pathogenesis & Vaccines
Dr Andrea Marzi, National Institutes of Health, USA
 
New Insight into the Pathogenesis of Zika Virus Infection
Prof Michael Diamond, Washington University, USA

ICV-Plenary
New and Emerging Viruses II

How Do Bats Coexist With Viruses?
Prof Michelle Baker, CSIRO Australian Animal Health Laboratory, Australia
 
Prof George Gao, Chinese Center for Disease Control and Prevention, China

Yakult Sponsored Lunch Symposium

Gut Microbiota and Ulcerative Colitis
Prof Toshifumi Ohkusa, The Jikei University Kashiwa Hospital

Workshop Sessions 3

  • Viral Diagnostics
    Prof Hossein Salimnia, Detroit Medical Center University Laboratories, USA
     
  • DNA Viruses I
    Prof Andrew Davison, University of Glasgow Centre for Virus Research, UK
     
  • Plant Viruses I
    Prof Manfred Heinlein, Institut de Biologie Moléculaire des Plantes du CNRS, Université de Strasbourg, France
     
  • Arboviruses I
    Prof Paul Young, The University of Queensland, Australia

Workshop Sessions 4

  • Virus Discovery
    Prof Eddie Holmes, The University of Sydney, Australia
     
  • DNA Viruses II
    Prof Andrew Davison, University of Glasgow Centre for Virus Research, UK
     
  • Plant Viruses II
    Prof Manfred Heinlein, Institut de Biologie Moléculaire des Plantes du CNRS, Université de Strasbourg, France
     
  • Arboviruses II
    Dr Lisa Ng, Singapore Immunology Network, A*STAR, Singapore

Special Supplement Session

Characterization of Dengue Virus NS2A Reveals Complicated Intra- and Inter- (NS2A & NS2B) Molecular Interactions Involved in Viral RNA Replication, Virus Assembly, and Virus-Induced Cytopathic
Prof Andrew Yeah, National Health Research Institutes, Taiwan

Bridging Sessions
Microbial Evolution and Diversity

Prof Martin Polz, MIT Boston, USA
 
Prof Antonis Rokas, Vanderbilt University, USA
 
Prof Eddie Holmes, University of Sydney, Australia

ICV-Plenary
Virus Structure and Macromolecular Assemblies I

How Poxvirus Fashion Membranes and Crystals Into Infectious Particles
Prof Fasseli Coulibaly, Monash University, Australia
 
Prof Shee-Mei Lok, Duke-NUS Medical School, Singapore

ICV-Plenary
Virus Structure and Macromolecular Assemblies II

Prof Janet Smith, University of Michigan, USA
 
Engineering and Structures of the MERS-CoV Spike Suggest a Mechanism for Receptor-Induced Triggering
Dr Jason McLellan, Geisel School of Medicine, USA

Workshop Sessions 5

  • Virus Vaccines
    Prof Eng Eong Ooi, Duke-NUS Medical School, Singapore
    Dr Karin Sundstrom, Duke-NUS Medical School, Singapore
     
  • Antivirals I
    Prof Subhash Vasudevan, Duke-NUS Medical School, Singapore
     
  • Hepatitis Viruses I
    Prof Tan Yee Joo, National University of Singapore, Singapore
     
  • Double Strand RNA Viruses
    Dr Masayuki Saijo, National Institute of Infectious Diseases, Japan

Workshop Sessions 6

  • Viral Evolution and Population Genetics
    Prof Alexander Gorbalenya, Leiden University Medical Center, Netherlands
     
  • Antivirals II
    Prof Subhash Vasudevan, Duke-NUS Medical School, Singapore
     
  • Hepatitis Viruses II
    Prof Tan Yee Joo, National University of Singapore, Singapore
     
  • Negative Strand RNA Viruses
    Dr Greg Moseley, The University of Melbourne, Australia

Special Supplement Session

Repurposing of Signal Transduction Inhibitors to Fight the Flu – MEK Inhibitors Efficiently Block Influenza Virus Replication in Mice with a Prolonged Therapeutic Window
Prof Stephan Ludwig, University of Muenster, Germany

Bridging Sessions
Microbes and Climate Change

Carlos Pedrós-Alió, National Center for Biotechnology (CSIC) in Madrid, Spain
 
Prof Lynne Boddy, Cardiff School of Biosciences, UK

ICV-Plenary
Viruses as Trojan Horses I

Prof John Bell, Ottawa Hospital Research Institute, Canada
 
Modular Design and Assembly of Synthetic Virus Vectors, Diagnostics and Cancer Therapies
Prof Clodagh O’Shea, Salk Institute, USA

ICV-Plenary
Viruses as Trojan Horses II

Prof Luk Vandenberghe, Schepens Eye Research Institute, USA
 
Prof Junghae Suh, Rice University, USA

Workshop Sessions 7

  • Innate Defense Against Viruses
    Prof Yongliang Zhang, National University of Singapore, Singapore
     
  • Viral Disease
    Dr Lara Herrero, Griffith University, Australia
     
  • Virus Surveillance, Epidemiology & Public Health
    Dr Julian Tang, University of Leicester, UK
     
  • Viruses & Cancer
    Prof Kah Whye Peng, Mayo Clinic, USA

Workshop Sessions 8

  • Antiviral Immunity
    Prof Lars Hangartner, The Scripps Research Institute, USA
     
  • RNA-Protein Interactions
    Prof Julia Kenyon, Homerton College University of Cambridge, UK
     
  • Viruses and microRNA
    Prof Ruey-Yi Chang, National Dong Hwa University, Taiwan
     
  • HIV and Retroviruses
    Prof David Harrich, QIMR Berghofer Medical Research Institute

Special Supplement Session

The Last 30 Years of Bacteriophage and Lytic Enzymes
Prof David Trudil, Eliava Institute of Bacteriophage, USA

Bridging Sessions
Immunity and Immune Evasion

Dr Mariagrazia Pizza, GlaxoSmithKline Biologicals, Italy
 
Prof Stuart Levitz, University of Massachusetts, USA
 
Dr Tiffany Reese, UT Southwestern Medical Center, USA

ICV-Plenary
Novel Approaches to Virus Control I

Prof David Harrich, QIMR Berghofer Medical Research Institute, Australia
 
The Use of Wolbachia to Control the Transmission of Aedes Aegypti Associated Viruses: The Eliminate Dengue Program
Prof Scott O’Neill, Monash University, Australia

ICV-Plenary
Novel Approaches to Virus Control II

Antivirals, A Lot Has Been Achieved, Yet A Long Way To Go
Prof Johan Neyts, University of Leuven, Belgium
 
Prof Ben TenOever, Icahn School of Medicine at Mount Sinai, USA

*Updated as of 16 June 2017. Programme is subjected to changes.